NATALIE MILES: Open Payments
NPI 1912616574 · PORT CHARLOTTE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 55 payments from 19 companies in 2025. Trend: 2023 $15 · 2024 $1,210 · 2025 $1,016
Food & beverage: $931Education: $85
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 15 | $222 |
| AstraZeneca Pharmaceuticals LP | 7 | $121 |
| SOBI, INC | 2 | $100 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Lilly USA, LLC | 4 | $63 |
| Merck Sharp & Dohme LLC | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $52 |
| Gilead Sciences, Inc. | 3 | $51 |
| ARRAY BIOPHARMA INC | 2 | $37 |
| Celgene Corporation | 2 | $33 |
Products named: Enhertu, INJECTAFER, VERZENIO, KISQALI, KEYTRUDA, Nubeqa, Trodelvy, OPDIVO.
Industry payments across FL — which companies pay providers there.
